Hypera S.A. (HYPE3.SA)
BRL 16.8
(-5.46%)
BRL 16.8
(-5.46%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 2.61 BRL | -2.61% |
| 2022 | 2.68 BRL | 27.62% |
| 2021 | 2.10 BRL | 2.44% |
| 2020 | 2.05 BRL | 11.41% |
| 2019 | 1.84 BRL | 2.79% |
| 2018 | 1.79 BRL | 16.99% |
| 2017 | 1.53 BRL | -18.18% |
| 2016 | 1.87 BRL | 110.11% |
| 2015 | 0.89 BRL | 39.06% |
| 2014 | 0.64 BRL | 56.1% |
| 2013 | 0.41 BRL | 24.24% |
| 2012 | 0.33 BRL | 475.0% |
| 2011 | -0.09 BRL | -117.6% |
| 2010 | 0.50 BRL | -28.57% |
| 2009 | 0.70 BRL | 234.62% |
| 2008 | -0.52 BRL | -500.0% |
| 2007 | 0.13 BRL | 1513.04% |
| 2006 | -0.01 BRL | -109.42% |
| 2005 | 0.10 BRL | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.62 BRL | 26.53% |
| 2024 Q2 | 0.78 BRL | 25.81% |
| 2023 Q3 | 0.79 BRL | -1.25% |
| 2023 Q1 | 0.54 BRL | -20.59% |
| 2023 FY | - BRL | -2.61% |
| 2023 Q2 | 0.80 BRL | 48.15% |
| 2023 Q4 | 0.49 BRL | -37.97% |
| 2022 Q1 | 0.55 BRL | -5.17% |
| 2022 Q2 | 0.72 BRL | 30.91% |
| 2022 Q3 | 0.73 BRL | 1.39% |
| 2022 Q4 | 0.68 BRL | -6.85% |
| 2022 FY | - BRL | 27.62% |
| 2021 Q3 | 0.32 BRL | -57.33% |
| 2021 FY | - BRL | 2.44% |
| 2021 Q1 | 0.48 BRL | -4.0% |
| 2021 Q2 | 0.75 BRL | 56.25% |
| 2021 Q4 | 0.58 BRL | 81.25% |
| 2020 FY | - BRL | 11.41% |
| 2020 Q2 | 0.63 BRL | 65.79% |
| 2020 Q1 | 0.38 BRL | 0.0% |
| 2020 Q4 | 0.50 BRL | -9.09% |
| 2020 Q3 | 0.55 BRL | -12.7% |
| 2019 Q4 | 0.38 BRL | -11.63% |
| 2019 Q1 | 0.51 BRL | 4.08% |
| 2019 Q3 | 0.43 BRL | -18.87% |
| 2019 Q2 | 0.53 BRL | 3.92% |
| 2019 FY | - BRL | 2.79% |
| 2018 Q3 | 0.38 BRL | -13.64% |
| 2018 Q1 | 0.47 BRL | -27.69% |
| 2018 FY | - BRL | 16.99% |
| 2018 Q4 | 0.49 BRL | 28.95% |
| 2018 Q2 | 0.44 BRL | -6.38% |
| 2017 Q3 | 0.26 BRL | -10.34% |
| 2017 Q2 | 0.29 BRL | 7.41% |
| 2017 Q1 | 0.27 BRL | 179.41% |
| 2017 FY | - BRL | -18.18% |
| 2017 Q4 | 0.65 BRL | 150.0% |
| 2016 Q3 | 0.32 BRL | 14.29% |
| 2016 FY | - BRL | 110.11% |
| 2016 Q4 | -0.34 BRL | -206.25% |
| 2016 Q2 | 0.28 BRL | -82.39% |
| 2016 Q1 | 1.59 BRL | 1570.17% |
| 2015 Q2 | 0.18 BRL | 28.57% |
| 2015 Q3 | 0.12 BRL | -33.33% |
| 2015 Q4 | 0.10 BRL | -20.67% |
| 2015 FY | - BRL | 39.06% |
| 2015 Q1 | 0.14 BRL | 27.27% |
| 2014 Q1 | 0.14 BRL | 64.71% |
| 2014 Q4 | 0.11 BRL | -42.11% |
| 2014 Q3 | 0.19 BRL | 0.0% |
| 2014 FY | - BRL | 56.1% |
| 2014 Q2 | 0.19 BRL | 35.71% |
| 2013 Q3 | 0.13 BRL | 323.45% |
| 2013 Q2 | 0.03 BRL | -80.81% |
| 2013 Q1 | 0.16 BRL | -20.0% |
| 2013 FY | - BRL | 24.24% |
| 2013 Q4 | 0.08 BRL | -34.62% |
| 2012 Q4 | 0.20 BRL | 81.82% |
| 2012 Q1 | 0.07 BRL | 165.3% |
| 2012 Q2 | -0.05 BRL | -173.35% |
| 2012 Q3 | 0.11 BRL | 329.65% |
| 2012 FY | - BRL | 475.0% |
| 2011 Q4 | -0.10 BRL | 66.67% |
| 2011 Q1 | 0.08 BRL | -33.33% |
| 2011 FY | - BRL | -117.6% |
| 2011 Q2 | 0.08 BRL | 0.0% |
| 2011 Q3 | -0.30 BRL | -475.0% |
| 2010 FY | - BRL | -28.57% |
| 2010 Q3 | 0.16 BRL | 72.41% |
| 2010 Q2 | 0.09 BRL | -15.64% |
| 2010 Q4 | 0.12 BRL | -25.0% |
| 2010 Q1 | 0.11 BRL | -47.62% |
| 2009 Q2 | 0.33 BRL | 73.68% |
| 2009 Q1 | 0.19 BRL | 0.0% |
| 2009 FY | - BRL | 234.62% |
| 2009 Q4 | 0.21 BRL | 2000.0% |
| 2009 Q3 | 0.01 BRL | -96.97% |
| 2008 FY | - BRL | -500.0% |
| 2007 FY | - BRL | 1513.04% |
| 2006 FY | - BRL | -109.42% |
| 2005 FY | - BRL | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Blau Farmacêutica S.A. | 1.41 BRL | -85.106% |